Active Studies

Patients should contact a representative at each institution to find out what the current/actual status of the NABTC studies are for a particular institution.

• NABTC02-02

 
Phase I Trial of R115777 with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme
• NABTC01-08

 
Phase II Trial of STI571 in Patients with Recurrent Meningioma
• NABTC01-03

 
A Phase I/II Trial of OSI-774 in Patients with Recurrent Malignant Gliomas Post Radiation Therapy
• NABTC 01-02

 
Phase I Study of ZD1839 and Temozolomide for the Treatment of Malignant Glioma
• NABTC 01-01

 
Phase I-II Trial of CCI-779 in Patients with Malignant Glioma
• NABTC 00-01

 
ZD1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Glioblastoma and Recurrent or Progressive Meningioma: A Phase II Study with a Phase I Component for Patients Receiving EIAEDs
• NABTC 99-08

 
Phase I-II Trial of STI571 in Patients with Recurrent Malignant Glioma and Meningioma
• NABTC 99-07
 
Phase I-II Trial of CPT-11 and Temozolomide (Temodar) in Patients with Recurrent Malignant Glioma
 
• NABTC 99-05
• NABTC 99-02
• NABTC 99-01
 
A Phase I and II Trial of R115777 in Patients with Recurrent Malignant Gliomas
 
• NABTC 98-01